Wetherby Asset Management Inc Dexcom Inc Transaction History

Wetherby Asset Management Inc

$2.04 Billion
Q4 2024

A detailed history of Wetherby Asset Management Inc transactions in Dexcom Inc stock. As of the latest transaction made, Wetherby Asset Management Inc holds 7,456 shares of DXCM stock, worth $654,711. This represents 0.03% of its overall portfolio holdings.

Number of Shares

7,456

Previous 6,416 16.21%

Holding current value

$654,711

Previous $430,000 34.65%

% of portfolio

0.03%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$65.68 - $81.01 $68,307 - $84,250	1,040 Added 16.21%	7,456 $579,000
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $203,776 - $369,535	-3,184 Reduced 33.17%	6,416 $430,000
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $98,286 - $125,140	-891 Reduced 8.49%	9,600 $1.09 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $7,081 - $8,686	-62 Reduced 0.59%	10,491 $1.46 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $48,766 - $80,207	646 Added 6.52%	10,553 $1.31 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $45,611 - $73,102	-530 Reduced 5.08%	9,907 $924,000
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $9,672 - $11,264	-86 Reduced 0.82%	10,437 $1.34 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $5,824 - $6,883	56 Added 0.54%	10,523 $1.22 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $51,327 - $74,092	604 Added 6.12%	10,467 $1.19 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $123,763 - $152,665	1,621 Added 19.67%	9,863 $794,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $373,333 - $729,698	5,491 Added 199.6%	8,242 $614,000
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $6,867 - $9,504	73 Added 2.73%	2,751 $1.41 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $4,805 - $6,024	37 Added 1.4%	2,678 $1.44 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $8,856 - $11,883	83 Added 3.24%	2,641 $1.44 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $84,877 - $113,110	1,048 Added 69.4%	2,558 $1.09 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $96,745 - $119,508	-1,141 Reduced 43.04%	1,510 $543,000
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $72,540 - $97,185	930 Added 54.04%	2,651 $980,000
Q3 2020 Dec 16, 2020	SELL	$95.51 - $112.95 $105,538 - $124,809	-1,105 Reduced 39.1%	1,721 $710,000
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $104,678 - $123,793	1,096 Added 63.35%	2,826 $1.17 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $17,675 - $29,705	282 Added 19.48%	1,730 $701,000
Q1 2020 May 06, 2020	BUY	$47.79 - $75.63 $18,494 - $29,268	387 Added 36.48%	1,448 $390,000
Q4 2019 Jan 28, 2020	BUY	$36.62 - $57.29 $38,853 - $60,784	1,061 New	1,061 $232,000

Others Institutions Holding DXCM

# of Institutions

1,083

Shares Held

351M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Account

Wetherby Asset Management Inc Dexcom Inc Transaction History